1. Home
  2. PGEN vs TLS Comparison

PGEN vs TLS Comparison

Compare PGEN & TLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PGEN
  • TLS
  • Stock Information
  • Founded
  • PGEN 1998
  • TLS 1969
  • Country
  • PGEN United States
  • TLS United States
  • Employees
  • PGEN N/A
  • TLS N/A
  • Industry
  • PGEN Biotechnology: Pharmaceutical Preparations
  • TLS EDP Services
  • Sector
  • PGEN Health Care
  • TLS Technology
  • Exchange
  • PGEN Nasdaq
  • TLS Nasdaq
  • Market Cap
  • PGEN 292.6M
  • TLS 246.1M
  • IPO Year
  • PGEN N/A
  • TLS 2020
  • Fundamental
  • Price
  • PGEN $0.86
  • TLS $3.31
  • Analyst Decision
  • PGEN Buy
  • TLS Buy
  • Analyst Count
  • PGEN 5
  • TLS 6
  • Target Price
  • PGEN $7.00
  • TLS $4.80
  • AVG Volume (30 Days)
  • PGEN 914.1K
  • TLS 879.4K
  • Earning Date
  • PGEN 11-14-2024
  • TLS 11-12-2024
  • Dividend Yield
  • PGEN N/A
  • TLS N/A
  • EPS Growth
  • PGEN N/A
  • TLS N/A
  • EPS
  • PGEN N/A
  • TLS N/A
  • Revenue
  • PGEN $3,963,000.00
  • TLS $122,959,000.00
  • Revenue This Year
  • PGEN N/A
  • TLS N/A
  • Revenue Next Year
  • PGEN $426.76
  • TLS $38.31
  • P/E Ratio
  • PGEN N/A
  • TLS N/A
  • Revenue Growth
  • PGEN N/A
  • TLS N/A
  • 52 Week Low
  • PGEN $0.77
  • TLS $1.89
  • 52 Week High
  • PGEN $1.93
  • TLS $5.03
  • Technical
  • Relative Strength Index (RSI)
  • PGEN 46.92
  • TLS 43.10
  • Support Level
  • PGEN $0.84
  • TLS $3.10
  • Resistance Level
  • PGEN $0.97
  • TLS $3.48
  • Average True Range (ATR)
  • PGEN 0.07
  • TLS 0.17
  • MACD
  • PGEN 0.00
  • TLS -0.02
  • Stochastic Oscillator
  • PGEN 46.90
  • TLS 24.71

About PGEN Precigen Inc.

Precigen Inc is a biotechnology company that develops synthetic biology solutions. The company designs build and regulate gene programs. Its technologies are broadly applicable across a wide range of diverse end markets. Intrexon's business model is to commercialize its technologies through exclusive channel collaborations with collaborators that have specific industry expertise, development resources, and sales and marketing capabilities, in order to bring new and improved products and processes to market. Its reportable segments are Biopharmaceuticals and Exemplar. The company's collaborators provide compensation through technology access fees, royalties, milestones, and reimbursement of certain costs.

About TLS Telos Corporation

Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.

Share on Social Networks: